Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAM-Cal: Phenotypic Characterization of Enamel Renal Syndrome
NCT07285421Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Glomerular filtration rate at 18 months. Planned start Jan 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07285421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07285421.